Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02706756

Conservative Intervention of Femoroacetabular Impingement Syndrome

Conservative Intervention of Femoroacetabular Impingement Syndrome: A Randomized Controlled Trial

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Duke University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

1. Purpose: 1) compare three conservative treatment approaches for subjects with femoroacetabular impingement syndrome (FAI), and 2) analyze functional outcome comparatively across groups. 2. Interventions will be provided based on randomized assignment. Group 1 will receive treatment based on identified impairments and treated twice weekly to address said impairments with hip manual therapy and exercise, as well as a prescriptive exercise for strengthening and mobility of the hip. Group 2 will receive only the prescriptive exercise program. Group 3 will be a control group (supervised neglect) 3. Primary outcomes data analysis will involve a mixed design (repeated measures) ANOVA for assessment of the primary outcome measure of the HAGOS. Secondary analyses will include chi square analyses (PASS, surgery at 6 months, adverse events), ANCOVA (PPMs, and expectations measures), or other appropriate comparative measures. None of the proposed treatment is considered outside of 'standard of practice'.

Conditions

Interventions

TypeNameDescription
OTHERManual therapyHip joint and spine manual therapy techniques applied toward the impairments of the subject.
OTHERExercisePrescriptive exercise program of self-mobilization and/or strengthening program to address impairments of the subject.
OTHEREducation and adviceAll three groups will receive standardized education on the current state of FAI interventions (with both conservative and surgical care).
OTHERSupervised neglectMonitoring of group without formal intervention.

Timeline

Start date
2016-03-01
Primary completion
2018-03-01
Completion
2018-03-01
First posted
2016-03-11
Last updated
2017-02-06

Source: ClinicalTrials.gov record NCT02706756. Inclusion in this directory is not an endorsement.